[Evaluation on Programs Regarding the Community-based Management of Hypertension and Type 2 Diabetes Mellitus Patients in Eight Provinces, China]
Overview
Authors
Affiliations
Objective: To understand the situation and efficacy of community-based management programs on hypertension and type 2 diabetes mellitus patients in primary health service centers.
Methods: In eight provinces being selected, a stratified multistage random sampling method was used to survey 5 116 cases of hypertension patients and 3 586 cases of type 2 diabetes mellitus patients aged over 35 years who had been under the management program for over 1 year. Face-to-face questionnaire interview and physical and biochemical examination were applied to collect related information, blood pressure and situation of glucose control.
Results: The rates of management on hypertension patients and type 2 diabetes mellitus patients were 23.6% (urban:17.1%, rural:28.1%, χ² = 27 195.33, P < 0.001)and 19.1% (urban:14.1%, rural:23.8%, χ² = 7 423.67, P < 0.001)while the standardized management rates were 61.1% (urban:63.3%, rural:58.6%, χ² = 11.82, P < 0.001)and 59.0% (urban:61.5%, rural:55.6%, χ² = 12.66, P < 0.001), respectively. Rate on blood pressure control among hypertension patients and the rate on fasting glucose control on type 2 diabetes mellitus patients were 50.3% (urban:62.0%, rural:36.6%, χ² = 329.31, P < 0.001)and 53.9% (urban:60.8%, rural:44.7%, χ² = 90.53, P < 0.001), respectively. Satisfaction rates for the management service of the hypertension patients and type 2 diabetes mellitus patients were 83.0% (urban:84.7% , rural: 80.7% , χ² = 13.42, P < 0.001) and 84.5% (urban:88.0% , rural:79.5% , χ² = 43.90, P < 0.001), respectively.
Conclusion: Efficiency was achieved to some extent in managing hypertension and type 2 diabetes mellitus patients in primary health service centers. Further improvement was expected on rates regarding management, standardized management and control on both blood pressure and glucose.
Zhang M, Shi Y, Zhou B, Huang Z, Zhao Z, Li C BMJ. 2023; 380:e071952.
PMID: 36631148 PMC: 10498511. DOI: 10.1136/bmj-2022-071952.
Yan L, Ji N, Xu J, Liu M, Guan L, Liu K China CDC Wkly. 2022; 4(19):411-416.
PMID: 35685125 PMC: 9167602. DOI: 10.46234/ccdcw2022.093.
Ye L, Fang T, Cui J, Zhu G, Ma R, Sun Y Hum Vaccin Immunother. 2020; 17(1):106-118.
PMID: 32460620 PMC: 7877400. DOI: 10.1080/21645515.2020.1761201.
Yao J, Wang H, Yin J, Shao D, Guo X, Sun Q BMC Health Serv Res. 2020; 20(1):407.
PMID: 32393254 PMC: 7212576. DOI: 10.1186/s12913-020-05292-5.
Zuo H, Ma J, Wang J, Chen X, Hou L J Hum Hypertens. 2019; 33(6):466-474.
PMID: 30647461 DOI: 10.1038/s41371-018-0158-7.